SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPuma Vct 13 Plc Regulatory News (PU13)

Share Price Information for Puma Vct 13 Plc (PU13)

Share Price is delayed by 15 minutes
Get Live Data
117.50    0.00 (0.00%)
Bid:
110.00
Ask:
125.00
Spread: 15.00 (13.636%)
Market Cap: £242.94m
PU13 Live PriceLast checked at - London Stock Exchange

Intraday Puma Vct 13 Plc Share Chart

Miscellaneous

5 Aug 2021 09:50

RNS Number : 6908H
Puma VCT 13 PLC
05 August 2021
 

 

Puma VCT 13 plc (the "Company")

 

Statement re Amendment of Investment Management Arrangements

 

Pursuant to a deed of amendment and restatement, the Company and Puma Investment Management Limited ("PIML"), with effect from 4 August 2021 the provisions for the reimbursement of fees and expenses in the investment management agreement between the Company and PIML (the "IMA") have been amended (increasing the caps applicable to the fees/expenses payable by the investee companies to PIML in relation to arrangement, structuring and monitoring fees and expenses, and clarifying the position regarding monitoring expenses that are to be incurred by the Company). Further to the amended terms of the IMA, any additional fees/expenses payable to PIML by the investee companies as a result of the amendment to the IMA should not in any twelve month period be £246,000 more than the aggregate of all fees and expenses that PIML could have charged the investee companies under the provisions of the IMA that were in effect prior to the amendment of the IMA in respect of that twelve month period.

 

PIML, as the investment manager of the Company, is a related party of the Company under the Listing Rules, and the amendment of the IMA as described above is a transaction to which Listing Rule 11.1.10R applies.

 

For further information please contact Rupert West on 0207 408 4050.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPPSELDFEEA
Date   Source Headline
17th Mar 202511:48 amRNSIssue of Equity
4th Mar 202511:31 amRNSIssue of Equity
3rd Feb 202510:41 amRNSPortfolio Update
31st Jan 20251:33 pmRNSTotal Voting Rights
29th Jan 202511:45 amRNSIssue of Equity
16th Jan 20255:44 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20253:27 pmRNSNet Asset Value(s)
9th Jan 202512:29 pmRNSIssue of Equity
31st Dec 202412:23 pmRNSTotal Voting Rights
17th Dec 202412:44 pmRNSIssue of Equity
29th Nov 20244:30 pmRNSTotal Voting Rights
20th Nov 202411:15 amRNSIssue of Equity
8th Nov 202410:57 amRNSHalf-year Report
31st Oct 20244:29 pmRNSTotal Voting Rights
29th Oct 202411:25 amRNSIssue of Equity
21st Oct 202411:44 amRNSIssue of Equity
18th Oct 20249:58 amRNSNet Asset Value
30th Sep 20244:05 pmRNSTotal Voting Rights
24th Sep 202412:47 pmRNSOffer for Subscription
24th Sep 202412:37 pmRNSDividend Declaration
19th Sep 20244:41 pmRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20244:25 pmRNSTotal Voting Rights
17th Sep 20245:42 pmRNSTransaction in Own Shares and Total Voting Rights
30th Aug 202411:19 amRNSIntention to Fundraise
22nd Aug 202412:15 pmRNSIntroduction of a Dividend Reinvestment Scheme
13th Aug 20244:16 pmRNSResult of AGM
1st Aug 202411:11 amRNSTotal Voting Rights
29th Jul 20244:51 pmRNSPortfolio Update
9th Jul 202412:27 pmRNSIssue of Equity
27th Jun 202411:53 amRNSIssue of Second Supplementary Prospectus
25th Jun 20243:41 pmRNSNet Asset Value
14th Jun 20241:34 pmRNSAnnual Financial Report
5th Jun 202410:43 amRNSOffer for Subscription – Update
31st May 20244:52 pmRNSTotal Voting Rights
23rd May 20242:33 pmRNSIssue of Equity
30th Apr 20244:51 pmRNSTotal Voting Rights
25th Apr 202411:57 amRNSIssue of Equity
3rd Apr 20241:41 pmRNSIssue of Equity
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20241:44 pmRNSIssue of Equity
18th Mar 20242:17 pmRNSIssue of Equity
12th Mar 20242:02 pmRNSIssue of Supplementary Prospectus
27th Feb 202412:46 pmRNSNet Asset Value(s)
31st Jan 20243:19 pmRNSIssue of Equity and Total Voting Rights
25th Jan 202411:10 amRNSPortfolio Update
18th Jan 20242:19 pmRNSIssue of Equity
4th Jan 202410:57 amRNSPortfolio Update
29th Dec 202310:14 amRNSTotal Voting Rights
11th Dec 202312:55 pmRNSIssue of Equity
30th Nov 20234:52 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.